Joshua M. Scurll

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer.

ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer.

Journal: JCI insight
Published: August 08, 2025

Author Correction: Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.

Author Correction: Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.

Journal: Nature communications
Published: February 21, 2025

Can a Molecular Classifier of Upper Tract Urothelial Carcinoma Inform Clinical Decision-making and Biological Stratification?

Can a Molecular Classifier of Upper Tract Urothelial Carcinoma Inform Clinical Decision-making and Biological Stratification?

Journal: European urology
Published: November 08, 2024

The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.

The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.

Journal: Epigenomics
Published: September 03, 2024

ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer.

ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer.

Journal: JCI insight
Published: August 14, 2024

Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.

Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy.

Journal: Nature communications
Published: April 15, 2024

A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer.

A genome-wide CRISPR screen maps endogenous regulators of PPARG gene expression in bladder cancer.

Journal: iScience
Published: October 06, 2022

An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity.

An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity.

Journal: Nature communications
Published: March 08, 2022

Phase separation and clustering of an ABC transporter in Mycobacterium tuberculosis.

Phase separation and clustering of an ABC transporter in Mycobacterium tuberculosis.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 02, 2019

Arp2/3 complex-driven spatial patterning of the BCR enhances immune synapse formation, BCR signaling and B cell activation.

Arp2/3 complex-driven spatial patterning of the BCR enhances immune synapse formation, BCR signaling and B cell activation.

Journal: eLife
Published: December 20, 2018

Limitations of Qdot labelling compared to directly-conjugated probes for single particle tracking of B cell receptor mobility.

Limitations of Qdot labelling compared to directly-conjugated probes for single particle tracking of B cell receptor mobility.

Journal: Scientific reports
Published: May 18, 2017

Quantitative Mass Spectrometry Identifies Novel Host Binding Partners for Pathogenic Escherichia coli Type III Secretion System Effectors.

Quantitative Mass Spectrometry Identifies Novel Host Binding Partners for Pathogenic Escherichia coli Type III Secretion System Effectors.

Journal: Journal of proteome research
Published: March 29, 2016
Showing 1-12 of 13

Last Updated: 09/26/2026